Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias

UPECLIN HC FM Botucatu Unesp

Status

Completed

Conditions

Telangiectasis

Treatments

Procedure: Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)

Study type

Observational

Funder types

Other

Identifiers

NCT05860439

UPECLIN233283

Details and patient eligibility

About

A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone.

All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up.

No new treatments were applied to the cohort.

Enrollment

191 patients

Sex

Female

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients that concluded the participation of 60 days in both primary studies were invited to reevaluate the actual status of treatment (maintenance of treated vessels) and late complications (pigmentation and matting).

Exclusion criteria

Patients who did not agree to be reassessed;
Patients who were not found after all available forms of contact had been tried;
Patients who went through any kind of intervention on the area of interest in lower limbs between the end of the intervention and the reevaluation for long-term follow-up.